-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Achilles Therapeutics plc quarterly Deferred Tax Assets, Operating Loss Carryforwards history and change rate from Q4 2019 to Q4 2023.
- Achilles Therapeutics plc Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Dec 2023 was $30.4M, a 13.3% decline year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)